Abstract
The scaffolding protein, hematopoietic PBX-interacting protein (HPIP/PBXIP1), regulates cell migration necessary for cancer cell dissemination. However, the mechanism that governs this process remains unknown. We show here that HPIP expression is associated with stages of breast cancer where cell dissemination results in poor patient outcome. Our investigation finds a novel association of HPIP with focal adhesion kinase (FAK) regulating FA dynamics. Interestingly, this interaction that led to activation of FAK protein was mediated by the C-terminal domain of HPIP and not the typical integrin-binding motif. Further, short hairpin RNA-mediated knockdown of FAK expression significantly reduced HPIP-induced cell migration indicating participation of FAK pathway. Live-cell time-lapse imaging and biochemical analysis further established the role of HPIP in microtubule-induced FA disassembly. We also found that HPIP-mediated MAPK activation led to phosphorylation and subsequent activation of calpain2, and the activated calpain2 in turn proteolyses FA protein, talin. Interestingly, HPIP is also proteolysed by calpain2 in breast cancer cells. The proteolysis of HPIP and talin by calpain2, and the activation of calapin2 by HPIP-mediated MAPK phosphorylation, is a novel regulatory axis to modulate the cell migration signal. Together, we have determined HPIP as a novel activator of FAK and a new substrate of calpain2. These molecular interactions between HPIP and FAK, and HPIP and calpain2 regulate cell adhesion and migration through modulation of FA dynamics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting integrin pathways: mechanisms and advances in therapy
Signal Transduction and Targeted Therapy Open Access 02 January 2023
-
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein
Cell Death Discovery Open Access 29 July 2021
-
Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis
Nature Communications Open Access 18 January 2019
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout







References
Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS . Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005; 15: 138–145.
Desgrosellier JS, Cheresh DA . Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9–22.
Hynes RO . Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673–687.
Lauffenburger DA, Horwitz AF . Cell migration: a physically integrated molecular process. Cell 1996; 84: 359–369.
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G et al. Cell migration: integrating signals from front to back. Science 2003; 302: 1704–1709.
Goode BL, Drubin DG, Barnes G . Functional cooperation between the microtubule and actin cytoskeletons. Curr Opin Cell Biol 2000; 12: 63–71.
Rodriguez OC, Schaefer AW, Mandato CA, Forscher P, Bement WM, Waterman-Storer CM . Conserved microtubule-actin interactions in cell movement and morphogenesis. Nat Cell Biol 2003; 5: 599–609.
Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539–544.
Sieg DJ, Hauck CR, Schlaepfer DD . Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112 (Pt 16): 2677–2691.
Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY . Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996; 134: 793–799.
Golubovskaya VM . Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem 2010; 10: 735–741.
Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995; 55: 2752–2755.
Weiner TM, Liu ET, Craven RJ, Cance WG . Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993; 342: 1024–1025.
Calalb MB, Polte TR, Hanks SK . Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995; 15: 954–963.
Schaller MD . Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci 2010; 123: 1007–1013.
Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P . Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci 2005; 118: 4415–4425.
Ritt M, Guan JL, Sivaramakrishnan S . Visualizing and manipulating focal adhesion kinase regulation in live cells. J Biol Chem 2013; 288: 8875–8886.
Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC . A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr Biol 2003; 13: 1442–1450.
Stehbens S, Wittmann T . Targeting and transport: how microtubules control focal adhesion dynamics. J Cell Biol 2012; 198: 481–489.
Ezratty EJ, Partridge MA, Gundersen GG . Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol 2005; 7: 581–590.
Krylyshkina O, Kaverina I, Kranewitter W, Steffen W, Alonso MC, Cross RA et al. Modulation of substrate adhesion dynamics via microtubule targeting requires kinesin-1. J Cell Biol 2002; 156: 349–359.
Abramovich C, Shen WF, Pineault N, Imren S, Montpetit B, Largman C et al. Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA. J Biol Chem 2000; 275: 26172–26177.
Manavathi B, Lo D, Bugide S, Dey O, Imren S, Weiss MJ et al. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation. J Biol Chem 2012; 287: 5600–5614.
Manavathi B, Acconcia F, Rayala SK, Kumar R . An inherent role of microtubule network in the action of nuclear receptor. Proc Natl Acad Sci USA 2006; 103: 15981–15986.
Wang XH, Yang ZH, Zhang H, Ding LH, Li XR, Zhu C et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta 2008; 1783: 1220–1228.
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008; 14: 518–527.
Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010; 123: 725–731.
Panetti TS . Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci 2002; 7: d143–d150.
Mitra SK, Hanson DA, Schlaepfer DD . Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56–68.
Wu XY, Kodama A, Fuchs E . ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell 2008; 135: 137–148.
Scolz M, Widlund PO, Piazza S, Bublik DR, Reber S, Peche LY et al. GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration. PLoS ONE 2012; 7: e51259.
Glading A, Lauffenburger DA, Wells A . Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002; 12: 46–54.
Franco SJ, Rodgers MA, Perrin BJ, Han J, Bennin DA, Critchley DR et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004; 6: 977–983.
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA et al. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 2004; 24: 2499–2512.
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest 2013; 123: 630–645.
Wozniak MA, Modzelewska K, Kwong L, Keely PJ . Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004; 1692: 103–119.
Geiger B, Spatz JP, Bershadsky AD . Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol 2009; 10: 21–33.
Cooper LA, Shen TL, Guan JL . Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction. Mol Cell Biol 2003; 23: 8030–8041.
Nagano M, Hoshino D, Sakamoto T, Kawasaki N, Koshikawa N, Seiki M . ZF21 protein regulates cell adhesion and motility. J Biol Chem 2010; 285: 21013–21022.
Franco S, Perrin B, Huttenlocher A . Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 2004; 299: 179–187.
Chan KT, Bennin DA, Huttenlocher A . Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J Biol Chem 2010; 285: 11418–11426.
Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004; 6: 154–161.
Acknowledgements
We are grateful to Dr Elaine Fuchs, Rockefeller University, New York, for providing pBABE-FAK, DsRed2-zyxin and pEGFP-paxillin constructs, and Dr Sam Aparicio, British Columbia Cancer Agency, Vancouver, Canada, for providing pGIPz-FAKshRNA clones. This work was supported by Department of Biotechnology (DBT), India Grant Nos: BT/01/IYBA/2009, BT/PR11114/BRB/10/635/2008 and BT-BRB-TF-4-2013, and Department of Science and Technology (DST), Grant Nos: SB/SO/BB/013/2013, India (to BM). SB is Senior Research Fellow, Council for Scientific and Industrial Research, India (CSIR), India. The authors also acknowledge DBT-CREBB, UGC-PURSE, DST-FIST and UOH-SAP-CAS for providing the research facilities at University of Hyderabad.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Bugide, S., David, D., Nair, A. et al. Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics. Oncogene 34, 4601–4612 (2015). https://doi.org/10.1038/onc.2014.389
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2014.389
This article is cited by
-
Targeting integrin pathways: mechanisms and advances in therapy
Signal Transduction and Targeted Therapy (2023)
-
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein
Cell Death Discovery (2021)
-
Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis
Nature Communications (2019)
-
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
Cellular Oncology (2017)
-
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway
Oncogenesis (2016)